Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5 Methionine Enkephalin
2. 5-methionine Enkephalin
3. Enkephalin, 5-methionine
4. Enkephalin, Methionine
5. Met Enkephalin
6. Met(5)-enkephalin
7. Met-enkephalin
8. Methionine Enkephalin
1. Lupex
2. Chembl214392
3. Enkephalin, Methionine
4. (2s,5s,14s)-14-amino-5-benzyl-15-(4-hydroxyphenyl)-2-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecan-1-oic Acid
5. Opioid Growth Factor (ogf)
6. Chebi:6618
7. Metencefalina
8. Metenkefaline
9. Metenkefalinum
10. Nsc-374896
11. 2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic Acid
12. Methionine-enkephalin
13. Methionine_enkephalin
14. Menk
15. [met(5)]enkephalin
16. [met(5)]-enkephalin
17. M-enk
18. L-tyrosylglycylglycyl-l-phenylalanyl-l-methionine
19. L-tyr-gly-gly-l-phe-l-met
20. Schembl1880497
21. Dtxsid90974125
22. Bcp25058
23. Bdbm50189255
24. H-l-tyr-gly-gly-l-phe-l-met-oh
25. Nsc374896
26. Nci60_008880
27. Ft-0770482
28. L024015
29. (met5)-enkephalin; Ccris 4225; Tyr-gly-gly-phe-met-oh; Methionine Enkephalin;h-tyr-gly-gly-phe-met-oh
30. 2-(2-(2-(2-(2-amino-3-(4-hydroxyphenyl)propanamido)acetamido)acetamido)-3-phenylpropanamido)-4-(methylthio)butanoic Acid
31. N-[2-({2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxyethylidene}amino)-1-hydroxy-3-phenylpropylidene]methionine
Molecular Weight | 573.7 g/mol |
---|---|
Molecular Formula | C27H35N5O7S |
XLogP3 | -2.1 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 16 |
Exact Mass | 573.22571965 g/mol |
Monoisotopic Mass | 573.22571965 g/mol |
Topological Polar Surface Area | 225 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 847 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Neurotransmitter Agents
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4621
Submission : 1982-08-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6005
Submission : 1985-08-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6719
Submission : 1986-12-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12902
Submission : 1998-03-18
Status : Inactive
Type : II
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?